DURVALUMAB - INJECTION
PHONETIC PRONUNCIATION: (dur-VAL-ue-mab)
COMMON BRAND NAME(S): Imfinzi
GENERIC NAME(S): durvalumab
Uses
USES: Durvalumab is used to treat a certain type of bladder and urinary tract cancer. It is also used to treat lung cancer. It works by helping your immune system fight the cancer. This medication belongs to a class of drugs known as monoclonal antibodies.
How to use DURVALUMAB - INJECTION
HOW TO USE: Read the Medication Guide provided by your pharmacist before you start receiving durvalumab and each time you get a treatment. If you have any questions, ask your doctor or pharmacist. This medication is given by a health care professional. It is injected slowly into a vein over 60 minutes as directed by your doctor, usually every 2 weeks. This medication may cause a serious reaction during the injection. Tell your doctor right away if you have symptoms such as chills, flushing, itching, dizziness, or shortness of breath. Your doctor may stop your treatment for some time if you get serious side effects. Your doctor may also prescribe other medications (including corticosteroids such as prednisone) to treat side effects. To get the most benefit, do not miss any doses. To help you remember, mark the days on the calendar when you need to receive the medication.
Side Effects
Precautions
Interactions
Overdose
Images
Reviews
Faq for DURVALUMAB - INJECTION
Durvalumab is a medication used for the treatment of certain types of cancer, including bladder cancer, lung cancer, and head and neck cancer.
Durvalumab belongs to a class of drugs known as immune checkpoint inhibitors. It works by helping the immune system recognize and attack cancer cells.
The common side effects of Durvalumab include fatigue, diarrhea, rash, itching, nausea, and decreased appetite.
Durvalumab is given as an intravenous infusion (injection into a vein) by a healthcare professional.
The duration of Durvalumab treatment depends on the type and stage of cancer being treated. It may be given for a few weeks to several months.
Yes, Durvalumab is often used in combination with other cancer treatments such as radiation therapy or chemotherapy to improve treatment outcomes.
Durvalumab may harm an unborn baby, so it is not recommended during pregnancy. It is also unknown if the drug passes into breast milk, so breastfeeding should be avoided.
If you miss a scheduled dose of Durvalumab, contact your healthcare provider to discuss the next steps.
Durvalumab may cause serious immune-related side effects, which may affect various organs. Patients should be closely monitored for symptoms and report any new or worsening side effects to their doctor.
Disclaimer
IMPORTANT: HOW TO USE THIS INFORMATION: This is a summary and does NOT have all possible information about this product. This information does not assure that this product is safe, effective, or appropriate for you. This information is not individual medical advice and does not substitute for the advice of your health care professional. Always ask your health care professional for complete information about this product and your specific health needs.
No Reviews Yet